F-group (family)
284.1.1.3 Rotamase
Ligands and drugs
509
Member domains
146
with ligand contacts (≤ 4 Å)
28.7% of members
79
with DrugDomain annotations
15.5% of members
40
with a DrugBank compound
7.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 284.1.1.3 belongs to X-group 284 FKBP-like, which binds 9.3 ligand superclasses per 20 proteins, broader than 84% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02042 | 1PG | 2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol | 8 |
| DB04456 | TAS | Arsenous acid | 2 |
| DB00160 | ALA | Alanine | 1 |
| DB00172 | PRO | Proline | 1 |
| DB00755 | REA | Tretinoin | 1 |
| DB01766 | — | Beta-(2-Naphthyl)-Alanine | 1 |
| DB04447 | DTT | 1,4-Dithiothreitol | 1 |
| DB06867 | 16P | 3,6,9,12,15,18-HEXAOXAICOSANE | 1 |
| DB07407 | B21 | 5-(2-METHOXYPHENYL)-2-FUROIC ACID | 1 |
| DB07803 | G14 | 2-phenyl-1H-imidazole-4-carboxylic acid | 1 |
| DB12116 | KDH | Epigallocatechin gallate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| 12P | DODECAETHYLENE GLYCOL | 15 |
| CL | CHLORIDE ION | 11 |
| 1PG | 2-(2-{2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHANOL | 8 |
| 0BF | 8-(2-chloranylethanoyl)-4-[(5-naphthalen-1-ylfuran-2-yl)methyl]-1-thia-4,8-diazaspiro[4.5]decan-3-one | 4 |
| DTT | 2,3-DIHYDROXY-1,4-DITHIOBUTANE | 4 |
| 15P | POLYETHYLENE GLYCOL (N=34) | 2 |
| 2NV | 3,6,9,12,15-pentaoxaoctadecan-17-amine | 2 |
| 39X | 3-(6-fluoro-1H-benzimidazol-2-yl)-N-(naphthalen-2-ylcarbonyl)-D-alanine | 2 |
| 4BX | 3-(1H-benzimidazol-2-yl)propanoic acid | 2 |
| A1AET | 3-(fluorosulfonyl)-5-[(2-oxo-2H-1-benzopyran-3-yl)carbamoyl]benzoic acid | 2 |
| A1D9K | ~{N}-[(2~{S})-3-[1-[4-(4-cyanophenyl)phenyl]-1,2,3-triazol-4-yl]-1-[(3-oxidanylcyclobutyl)amino]-1-oxidanylidene-propan-2-yl]-1-phenyl-cyclopropane-1-carboxamide | 2 |
| A1EFQ | 1-(1H-pyrazol-3-yl)ethanone | 2 |
| GIA | 3-fluoro-N-(naphthalen-2-ylcarbonyl)-D-phenylalanine | 2 |
| ICB | 1H-indole-2-carboxylic acid | 2 |
| J8Z | (2R)-2-[(1-benzothiophen-2-ylcarbonyl)amino]-3-(3-methylphenyl)propyl phosphate | 2 |
| J9Z | (2R)-2-[(1-benzothiophen-2-ylcarbonyl)amino]-3-phenylpropyl phosphate | 2 |
| JZI | (2R,4E)-2-[(naphthalen-2-ylcarbonyl)amino]-5-phenylpent-4-enoic acid | 2 |
| TAS | TRIHYDROXYARSENITE(III) | 2 |
| 16P | 3,6,9,12,15,18-HEXAOXAICOSANE | 1 |
| 3T5 | (11alpha,16alpha)-9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl dihydrogen phosphate | 1 |